Old Web
English
Sign In
Acemap
>
authorDetail
>
William O. Wilkison
William O. Wilkison
Internal medicine
Endocrinology
Diabetes mellitus
Medicine
Biology
5
Papers
96
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Remogliflozin Etabonate Improves Fatty Liver Disease in Diet-Induced Obese Male Mice
2015
Journal of clinical and experimental hepatology
Shigeru Nakano
Kenji Katsuno
Masayuki Isaji
Tatsuya Nagasawa
Benjamin M. Buehrer
Susan Walker
William O. Wilkison
Bentley Cheatham
Show All
Source
Cite
Save
Citations (51)
Randomized efficacy and safety trial of once‐daily remogliflozin etabonate for the treatment of type 2 diabetes
2015
Diabetes, Obesity and Metabolism
Andy Sykes
Graham J. L. Kemp
Robert L. Dobbins
Robin L. O'Connor‐Semmes
Steve Almond
William O. Wilkison
Sarah M. Walker
Lata Kler
Show All
Source
Cite
Save
Citations (21)
Regulation of the Melanocortin Receptors by Agouti
2000
William O. Wilkison
Show All
Source
Cite
Save
Citations (3)
Effects of a potent melanocortin agonist on the diabetic/obese phenotype in yellow mice
1998
International Journal of Obesity
Michael B. Zemel
J. W. Moore
N. Moustaid
Jung Han Kim
James S Nichols
Steven G. Blanchard
Derek J. Parks
Cole O. Harris
FW Lee
M Grizzle
M James
William O. Wilkison
Show All
Source
Cite
Save
Citations (19)
The genetic basis of obesity in rodents
1996
Current Opinion in Endocrinology & Diabetes
William O. Wilkison
Show All
Source
Cite
Save
Citations (2)
1